Ticker

No recent analyst price targets found for KIO.

Latest News for KIO

KIO: Income May Increase Going Forward, But The Distribution Is Destroying NAV

The KKR Income Opportunities Fund offers a 12.95% yield but has suffered NAV and price declines, raising concerns about distribution sustainability. KIO's portfolio blends floating-rate senior loans and fixed-rate junk bonds, positioning it to benefit modestly from potential Fed rate hikes. Recent performance has lagged peers, with the fund paying out more than it earns, leading to destructive distributions and NAV…

Seeking Alpha • Jul 2, 2026
Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model

Data Presented at Epilepsy Foundation Pipeline Conference Demonstrated Significant Reduction in Epileptiform Activity: KIO-300 is the active pharmaceutical ingredient of KIO-301, Kiora's ongoing Phase 2 clinical program in vision restoration in patients with gene mutation-agnostic Retinitis Pigmentosa Encinitas, California--(Newsfile Corp. - June 18, 2026) - Kiora Pharmaceuticals (NASDAQ: KPRX) today announced…

Newsfile Corp • Jun 18, 2026
KKR Income Opportunities Fund Declares Monthly Distributions of $0.1215 Per Share

NEW YORK--(BUSINESS WIRE)--KKR Income Opportunities Fund (the “Fund”) (NYSE: KIO) today announced its monthly distributions of $0.1215 per common share, payable on the dates below. Based on the Fund's current share price of $11.26 per share (as of market close on June 5, 2026), the distributions represent an annualized distribution rate of 12.95% (calculated by annualizing the distribution amount and dividing it by…

Business Wire • Jun 8, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for KIO.

No House trades found for KIO.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top